PRKG1
cGMP-dependent protein kinase 1
Also known as: KGP1_HUMAN, PGK, PKG, PKG1, PRKG1B, PRKGR1B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13976
- Gene
- PRKG1
- Ensembl
- ENSG00000185532
- Chromosome
- 10
- Canonical length
- 671 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
671 residues, UniProt reviewed canonical sequence.
>Q13976|PRKG1
1 MSELEEDFAK ILMLKEERIK ELEKRLSEKE EEIQELKRKL HKCQSVLPVP STHIGPRTTR
61 AQGISAEPQT YRSFHDLRQA FRKFTKSERS KDLIKEAILD NDFMKNLELS QIQEIVDCMY
121 PVEYGKDSCI IKEGDVGSLV YVMEDGKVEV TKEGVKLCTM GPGKVFGELA ILYNCTRTAT
181 VKTLVNVKLW AIDRQCFQTI MMRTGLIKHT EYMEFLKSVP TFQSLPEEIL SKLADVLEET
241 HYENGEYIIR QGARGDTFFI ISKGTVNVTR EDSPSEDPVF LRTLGKGDWF GEKALQGEDV
301 RTANVIAAEA VTCLVIDRDS FKHLIGGLDD VSNKAYEDAE AKAKYEAEAA FFANLKLSDF
361 NIIDTLGVGG FGRVELVQLK SEESKTFAMK ILKKRHIVDT RQQEHIRSEK QIMQGAHSDF
421 IVRLYRTFKD SKYLYMLMEA CLGGELWTIL RDRGSFEDST TRFYTACVVE AFAYLHSKGI
481 IYRDLKPENL ILDHRGYAKL VDFGFAKKIG FGKKTWTFCG TPEYVAPEII LNKGHDISAD
541 YWSLGILMYE LLTGSPPFSG PDPMKTYNII LRGIDMIEFP KKIAKNAANL IKKLCRDNPS
601 ERLGNLKNGV KDIQKHKWFE GFNWEGLRKG TLTPPIIPSV ASPTDTSNFD SFPEDNDEPP
661 PDDNSGWDID FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRKG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 64 nTPM
- tongue: 34 nTPM
- skeletal muscle: 24 nTPM
- smooth muscle: 14 nTPM
- colon: 14 nTPM
- heart muscle: 13 nTPM
Single-cell type
- myonuclei: 4,254 nCPM
- vascular smooth muscle cells: 4,015 nCPM
- choroid plexus epithelial cells: 2,813 nCPM
- retinal ganglion cells: 2,708 nCPM
- pericytes: 2,669 nCPM
- podocytes: 2,490 nCPM
Immune cell
- basophil: 7.3 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 35 nTPM
- hypothalamus: 34 nTPM
- basal ganglia: 24 nTPM
- cerebral cortex: 22 nTPM
- amygdala: 22 nTPM
- hippocampal formation: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRKG1.
Disease | AllUniProt
Conditions PRKG1 is implicated in, by any mechanism.
- Aortic aneurysm, familial thoracic 8 (AAT8) MIM:615436
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 972 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Aortic aneurysm, familial thoracic 8
- Familial thoracic aortic aneurysm and aortic dissection
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.98
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone growth
- cell growth involved in cardiac muscle cell development
- cerebellum development
- cGMP-mediated signaling
- collateral sprouting
- dendrite development
- forebrain development
- negative regulation of glutamate secretion
- negative regulation of inositol phosphate biosynthetic process
- negative regulation of platelet aggregation
- negative regulation of vascular associated smooth muscle cell migration
- negative regulation of vascular associated smooth muscle cell proliferation
- neuron migration
- positive regulation of circadian rhythm
- positive regulation of cytosolic calcium ion concentration
- regulation of testosterone biosynthetic process
- regulation of vascular permeability
- relaxation of vascular associated smooth muscle
- signal transduction
- spermatid development
Molecular functions
- ATP binding
- calcium channel regulator activity
- cGMP binding
- cGMP-dependent protein kinase activity
- identical protein binding
- mitogen-activated protein kinase p38 binding
- protein kinase activity
- protein serine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cyclic nucleotide-binding domain
- Protein kinase domain
- AGC-kinase, C-terminal
- cGMP-dependent kinase
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- RmlC-like jelly roll fold
- Protein kinase, ATP binding site
- Cyclic nucleotide-binding, conserved site
- Cyclic nucleotide-binding domain superfamily
- cGMP-dependent protein kinase, catalytic domain
- Cyclic nucleotide-binding domain
- Protein kinase domain
- cGMP-dependent protein kinase, N-terminal coiled-coil domain
- Coiled-coil N-terminus of cGMP-dependent protein kinase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRKG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRKG1 as an antibody target. Whether an autoantibody or antibody against PRKG1 could matter depends on whether native PRKG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRKG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRKG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...